カテゴリー： 世界, 医療/バイオ, LP Information

世界のホスネツピタント＆塩酸パロノセトロンカプセル市場予測 2023年-2029年

【英語タイトル】Global Netupitant and Palonosetron Hydrochloride Capsules Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC11002）・商品コード：LP23DC11002
・発行会社（調査会社）：LP Information
・発行日：2023年11月（※2025年版があります。お問い合わせください。）
・ページ数：98
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のホスネツピタント＆塩酸パロノセトロンカプセル市場」は、過去の販売実績から2022年の世界のホスネツピタント＆塩酸パロノセトロンカプセルの総販売量を検討し、2023年から2029年の予測されるホスネツピタント＆塩酸パロノセトロンカプセルの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のホスネツピタント＆塩酸パロノセトロンカプセルの市場規模を掲載し、XXX百万米ドル規模の世界のホスネツピタント＆塩酸パロノセトロンカプセル市場の詳細な分析を提供します。本インサイトレポートは、世界のホスネツピタント＆塩酸パロノセトロンカプセル業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のホスネツピタント＆塩酸パロノセトロンカプセル市場における各社の独自のポジションをより深く理解するために、ホスネツピタント＆塩酸パロノセトロンカプセル製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のホスネツピタント＆塩酸パロノセトロンカプセル市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ホスネツピタント＆塩酸パロノセトロンカプセルの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。ホスネツピタント＆塩酸パロノセトロンカプセルの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ホスネツピタント＆塩酸パロノセトロンカプセルのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ホスネツピタント＆塩酸パロノセトロンカプセルの世界主要メーカーとしては、Helsinn Birex Pharmaceuticals Ltd、 Eurimpharm Arzneimittel GmbH、 Sichuan Kelun Pharmaceutical Co., Ltd、 CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD、 QILU PHARMACEUTICAL CO.,LTDなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のホスネツピタント＆塩酸パロノセトロンカプセル市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではホスネツピタント＆塩酸パロノセトロンカプセル市場をセグメンテーションし、種類別 (300mg/カプセル 1カプセル/箱、 0.5mg/カプセル 1カプセル/箱)、用途別 (中等度催吐性化学療法、高度催吐性化学療法)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：300mg/カプセル 1カプセル/箱、 0.5mg/カプセル 1カプセル/箱

・用途別区分：中等度催吐性化学療法、高度催吐性化学療法

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のホスネツピタント＆塩酸パロノセトロンカプセル市場の10年間の市場状況・展望は？
・世界および地域別に見たホスネツピタント＆塩酸パロノセトロンカプセル市場成長の要因は何か？
・ホスネツピタント＆塩酸パロノセトロンカプセルの市場機会はエンドマーケットの規模によってどのように変化するのか？
・ホスネツピタント＆塩酸パロノセトロンカプセルのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：ホスネツピタント＆塩酸パロノセトロンカプセルの年間販売量2018-2029、地域別現状・将来分析
・ホスネツピタント＆塩酸パロノセトロンカプセルの種類別セグメント：300mg/カプセル 1カプセル/箱、 0.5mg/カプセル 1カプセル/箱
・ホスネツピタント＆塩酸パロノセトロンカプセルの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・ホスネツピタント＆塩酸パロノセトロンカプセルの用途別セグメント：中等度催吐性化学療法、高度催吐性化学療法
・ホスネツピタント＆塩酸パロノセトロンカプセルの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のホスネツピタント＆塩酸パロノセトロンカプセル市場
・企業別のグローバルホスネツピタント＆塩酸パロノセトロンカプセル市場データ：2018-2023年の年間販売量、市場シェア
・企業別のホスネツピタント＆塩酸パロノセトロンカプセルの年間売上：2018-2023年の売上、市場シェア
・企業別のホスネツピタント＆塩酸パロノセトロンカプセル販売価格
・主要企業のホスネツピタント＆塩酸パロノセトロンカプセル生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ホスネツピタント＆塩酸パロノセトロンカプセルの地域別レビュー
・地域別のホスネツピタント＆塩酸パロノセトロンカプセル市場規模2018-2023：年間販売量、売上
・主要国別のホスネツピタント＆塩酸パロノセトロンカプセル市場規模2018-2023：年間販売量、売上
・南北アメリカのホスネツピタント＆塩酸パロノセトロンカプセル販売の成長
・アジア太平洋のホスネツピタント＆塩酸パロノセトロンカプセル販売の成長
・ヨーロッパのホスネツピタント＆塩酸パロノセトロンカプセル販売の成長
・中東・アフリカのホスネツピタント＆塩酸パロノセトロンカプセル販売の成長

南北アメリカ市場
・南北アメリカの国別のホスネツピタント＆塩酸パロノセトロンカプセル販売量、売上（2018-2023）
・南北アメリカのホスネツピタント＆塩酸パロノセトロンカプセルの種類別販売量
・南北アメリカのホスネツピタント＆塩酸パロノセトロンカプセルの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のホスネツピタント＆塩酸パロノセトロンカプセル販売量、売上（2018-2023）
・アジア太平洋のホスネツピタント＆塩酸パロノセトロンカプセルの種類別販売量
・アジア太平洋のホスネツピタント＆塩酸パロノセトロンカプセルの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のホスネツピタント＆塩酸パロノセトロンカプセル販売量、売上（2018-2023）
・ヨーロッパのホスネツピタント＆塩酸パロノセトロンカプセルの種類別販売量
・ヨーロッパのホスネツピタント＆塩酸パロノセトロンカプセルの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のホスネツピタント＆塩酸パロノセトロンカプセル販売量、売上（2018-2023）
・中東・アフリカのホスネツピタント＆塩酸パロノセトロンカプセルの種類別販売量
・中東・アフリカのホスネツピタント＆塩酸パロノセトロンカプセルの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ホスネツピタント＆塩酸パロノセトロンカプセルの製造コスト構造分析
・ホスネツピタント＆塩酸パロノセトロンカプセルの製造プロセス分析
・ホスネツピタント＆塩酸パロノセトロンカプセルの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・ホスネツピタント＆塩酸パロノセトロンカプセルの主要なグローバル販売業者
・ホスネツピタント＆塩酸パロノセトロンカプセルの主要なグローバル顧客

地域別のホスネツピタント＆塩酸パロノセトロンカプセル市場予測レビュー
・地域別のホスネツピタント＆塩酸パロノセトロンカプセル市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ホスネツピタント＆塩酸パロノセトロンカプセルの種類別市場規模予測
・ホスネツピタント＆塩酸パロノセトロンカプセルの用途別市場規模予測

主要企業分析
Helsinn Birex Pharmaceuticals Ltd、 Eurimpharm Arzneimittel GmbH、 Sichuan Kelun Pharmaceutical Co., Ltd、 CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD、 QILU PHARMACEUTICAL CO.,LTD
・企業情報
・ホスネツピタント＆塩酸パロノセトロンカプセル製品
・ホスネツピタント＆塩酸パロノセトロンカプセル販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Netupitant and Palonosetron Hydrochloride Capsules market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Netupitant and Palonosetron Hydrochloride Capsules is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Netupitant and Palonosetron Hydrochloride Capsules is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Netupitant and Palonosetron Hydrochloride Capsules is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Netupitant and Palonosetron Hydrochloride Capsules players cover Helsinn Birex Pharmaceuticals Ltd, Eurimpharm Arzneimittel GmbH, Sichuan Kelun Pharmaceutical Co., Ltd, CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD and QILU PHARMACEUTICAL CO.,LTD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Netupitant Palonosetron Capsules is a drug for the treatment of chemotherapy-related nausea and vomiting (CINV). It is the world’s first and only dual-channel oral compound drug that inhibits 5-HT3 receptors and NK1 receptors. Block the two key pathways of CINV, effectively antiemetic. At the same time, the convenience of the compound preparation also makes it have significant advantages in improving the compliance of clinicians’ guidelines and medication compliance of patients, and improving the management of CINV.
LPI (LP Information)’ newest research report, the “Netupitant and Palonosetron Hydrochloride Capsules Industry Forecast” looks at past sales and reviews total world Netupitant and Palonosetron Hydrochloride Capsules sales in 2022, providing a comprehensive analysis by region and market sector of projected Netupitant and Palonosetron Hydrochloride Capsules sales for 2023 through 2029. With Netupitant and Palonosetron Hydrochloride Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Netupitant and Palonosetron Hydrochloride Capsules industry.
This Insight Report provides a comprehensive analysis of the global Netupitant and Palonosetron Hydrochloride Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Netupitant and Palonosetron Hydrochloride Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Netupitant and Palonosetron Hydrochloride Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Netupitant and Palonosetron Hydrochloride Capsules and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Netupitant and Palonosetron Hydrochloride Capsules.
This report presents a comprehensive overview, market shares, and growth opportunities of Netupitant and Palonosetron Hydrochloride Capsules market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
300 mg/Capsule 1 Capsule/Box
0.5 mg/Capsule 1 Capsule/Box
Segmentation by application
Moderate Emetogenic Chemotherapy
Highly Emetogenic Chemotherapy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Helsinn Birex Pharmaceuticals Ltd
Eurimpharm Arzneimittel GmbH
Sichuan Kelun Pharmaceutical Co., Ltd
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD
QILU PHARMACEUTICAL CO.,LTD
Key Questions Addressed in this Report
What is the 10-year outlook for the global Netupitant and Palonosetron Hydrochloride Capsules market?
What factors are driving Netupitant and Palonosetron Hydrochloride Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Netupitant and Palonosetron Hydrochloride Capsules market opportunities vary by end market size?
How does Netupitant and Palonosetron Hydrochloride Capsules break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Netupitant and Palonosetron Hydrochloride Capsules Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Netupitant and Palonosetron Hydrochloride Capsules by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Netupitant and Palonosetron Hydrochloride Capsules by Country/Region, 2018, 2022 & 2029
2.2 Netupitant and Palonosetron Hydrochloride Capsules Segment by Type
2.2.1 300 mg/Capsule 1 Capsule/Box
2.2.2 0.5 mg/Capsule 1 Capsule/Box
2.3 Netupitant and Palonosetron Hydrochloride Capsules Sales by Type
2.3.1 Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Type (2018-2023)
2.3.2 Global Netupitant and Palonosetron Hydrochloride Capsules Revenue and Market Share by Type (2018-2023)
2.3.3 Global Netupitant and Palonosetron Hydrochloride Capsules Sale Price by Type (2018-2023)
2.4 Netupitant and Palonosetron Hydrochloride Capsules Segment by Application
2.4.1 Moderate Emetogenic Chemotherapy
2.4.2 Highly Emetogenic Chemotherapy
2.5 Netupitant and Palonosetron Hydrochloride Capsules Sales by Application
2.5.1 Global Netupitant and Palonosetron Hydrochloride Capsules Sale Market Share by Application (2018-2023)
2.5.2 Global Netupitant and Palonosetron Hydrochloride Capsules Revenue and Market Share by Application (2018-2023)
2.5.3 Global Netupitant and Palonosetron Hydrochloride Capsules Sale Price by Application (2018-2023)
3 Global Netupitant and Palonosetron Hydrochloride Capsules by Company
3.1 Global Netupitant and Palonosetron Hydrochloride Capsules Breakdown Data by Company
3.1.1 Global Netupitant and Palonosetron Hydrochloride Capsules Annual Sales by Company (2018-2023)
3.1.2 Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Company (2018-2023)
3.2 Global Netupitant and Palonosetron Hydrochloride Capsules Annual Revenue by Company (2018-2023)
3.2.1 Global Netupitant and Palonosetron Hydrochloride Capsules Revenue by Company (2018-2023)
3.2.2 Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Company (2018-2023)
3.3 Global Netupitant and Palonosetron Hydrochloride Capsules Sale Price by Company
3.4 Key Manufacturers Netupitant and Palonosetron Hydrochloride Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Netupitant and Palonosetron Hydrochloride Capsules Product Location Distribution
3.4.2 Players Netupitant and Palonosetron Hydrochloride Capsules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Netupitant and Palonosetron Hydrochloride Capsules by Geographic Region
4.1 World Historic Netupitant and Palonosetron Hydrochloride Capsules Market Size by Geographic Region (2018-2023)
4.1.1 Global Netupitant and Palonosetron Hydrochloride Capsules Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Netupitant and Palonosetron Hydrochloride Capsules Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Netupitant and Palonosetron Hydrochloride Capsules Market Size by Country/Region (2018-2023)
4.2.1 Global Netupitant and Palonosetron Hydrochloride Capsules Annual Sales by Country/Region (2018-2023)
4.2.2 Global Netupitant and Palonosetron Hydrochloride Capsules Annual Revenue by Country/Region (2018-2023)
4.3 Americas Netupitant and Palonosetron Hydrochloride Capsules Sales Growth
4.4 APAC Netupitant and Palonosetron Hydrochloride Capsules Sales Growth
4.5 Europe Netupitant and Palonosetron Hydrochloride Capsules Sales Growth
4.6 Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules Sales Growth
5 Americas
5.1 Americas Netupitant and Palonosetron Hydrochloride Capsules Sales by Country
5.1.1 Americas Netupitant and Palonosetron Hydrochloride Capsules Sales by Country (2018-2023)
5.1.2 Americas Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country (2018-2023)
5.2 Americas Netupitant and Palonosetron Hydrochloride Capsules Sales by Type
5.3 Americas Netupitant and Palonosetron Hydrochloride Capsules Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Netupitant and Palonosetron Hydrochloride Capsules Sales by Region
6.1.1 APAC Netupitant and Palonosetron Hydrochloride Capsules Sales by Region (2018-2023)
6.1.2 APAC Netupitant and Palonosetron Hydrochloride Capsules Revenue by Region (2018-2023)
6.2 APAC Netupitant and Palonosetron Hydrochloride Capsules Sales by Type
6.3 APAC Netupitant and Palonosetron Hydrochloride Capsules Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Netupitant and Palonosetron Hydrochloride Capsules by Country
7.1.1 Europe Netupitant and Palonosetron Hydrochloride Capsules Sales by Country (2018-2023)
7.1.2 Europe Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country (2018-2023)
7.2 Europe Netupitant and Palonosetron Hydrochloride Capsules Sales by Type
7.3 Europe Netupitant and Palonosetron Hydrochloride Capsules Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules by Country
8.1.1 Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules Sales by Country (2018-2023)
8.1.2 Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country (2018-2023)
8.2 Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules Sales by Type
8.3 Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Netupitant and Palonosetron Hydrochloride Capsules
10.3 Manufacturing Process Analysis of Netupitant and Palonosetron Hydrochloride Capsules
10.4 Industry Chain Structure of Netupitant and Palonosetron Hydrochloride Capsules
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Netupitant and Palonosetron Hydrochloride Capsules Distributors
11.3 Netupitant and Palonosetron Hydrochloride Capsules Customer
12 World Forecast Review for Netupitant and Palonosetron Hydrochloride Capsules by Geographic Region
12.1 Global Netupitant and Palonosetron Hydrochloride Capsules Market Size Forecast by Region
12.1.1 Global Netupitant and Palonosetron Hydrochloride Capsules Forecast by Region (2024-2029)
12.1.2 Global Netupitant and Palonosetron Hydrochloride Capsules Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Netupitant and Palonosetron Hydrochloride Capsules Forecast by Type
12.7 Global Netupitant and Palonosetron Hydrochloride Capsules Forecast by Application
13 Key Players Analysis
13.1 Helsinn Birex Pharmaceuticals Ltd
13.1.1 Helsinn Birex Pharmaceuticals Ltd Company Information
13.1.2 Helsinn Birex Pharmaceuticals Ltd Netupitant and Palonosetron Hydrochloride Capsules Product Portfolios and Specifications
13.1.3 Helsinn Birex Pharmaceuticals Ltd Netupitant and Palonosetron Hydrochloride Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Helsinn Birex Pharmaceuticals Ltd Main Business Overview
13.1.5 Helsinn Birex Pharmaceuticals Ltd Latest Developments
13.2 Eurimpharm Arzneimittel GmbH
13.2.1 Eurimpharm Arzneimittel GmbH Company Information
13.2.2 Eurimpharm Arzneimittel GmbH Netupitant and Palonosetron Hydrochloride Capsules Product Portfolios and Specifications
13.2.3 Eurimpharm Arzneimittel GmbH Netupitant and Palonosetron Hydrochloride Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Eurimpharm Arzneimittel GmbH Main Business Overview
13.2.5 Eurimpharm Arzneimittel GmbH Latest Developments
13.3 Sichuan Kelun Pharmaceutical Co., Ltd
13.3.1 Sichuan Kelun Pharmaceutical Co., Ltd Company Information
13.3.2 Sichuan Kelun Pharmaceutical Co., Ltd Netupitant and Palonosetron Hydrochloride Capsules Product Portfolios and Specifications
13.3.3 Sichuan Kelun Pharmaceutical Co., Ltd Netupitant and Palonosetron Hydrochloride Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sichuan Kelun Pharmaceutical Co., Ltd Main Business Overview
13.3.5 Sichuan Kelun Pharmaceutical Co., Ltd Latest Developments
13.4 CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD
13.4.1 CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Company Information
13.4.2 CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Netupitant and Palonosetron Hydrochloride Capsules Product Portfolios and Specifications
13.4.3 CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Netupitant and Palonosetron Hydrochloride Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Main Business Overview
13.4.5 CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Latest Developments
13.5 QILU PHARMACEUTICAL CO.,LTD
13.5.1 QILU PHARMACEUTICAL CO.,LTD Company Information
13.5.2 QILU PHARMACEUTICAL CO.,LTD Netupitant and Palonosetron Hydrochloride Capsules Product Portfolios and Specifications
13.5.3 QILU PHARMACEUTICAL CO.,LTD Netupitant and Palonosetron Hydrochloride Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 QILU PHARMACEUTICAL CO.,LTD Main Business Overview
13.5.5 QILU PHARMACEUTICAL CO.,LTD Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Netupitant and Palonosetron Hydrochloride Capsules Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Netupitant and Palonosetron Hydrochloride Capsules Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 300 mg/Capsule 1 Capsule/Box
Table 4. Major Players of 0.5 mg/Capsule 1 Capsule/Box
Table 5. Global Netupitant and Palonosetron Hydrochloride Capsules Sales by Type (2018-2023) & (K Units)
Table 6. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Type (2018-2023)
Table 7. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue by Type (2018-2023) & ($ million)
Table 8. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Type (2018-2023)
Table 9. Global Netupitant and Palonosetron Hydrochloride Capsules Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Netupitant and Palonosetron Hydrochloride Capsules Sales by Application (2018-2023) & (K Units)
Table 11. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Application (2018-2023)
Table 12. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue by Application (2018-2023)
Table 13. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Application (2018-2023)
Table 14. Global Netupitant and Palonosetron Hydrochloride Capsules Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Netupitant and Palonosetron Hydrochloride Capsules Sales by Company (2018-2023) & (K Units)
Table 16. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Company (2018-2023)
Table 17. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Company (2018-2023)
Table 19. Global Netupitant and Palonosetron Hydrochloride Capsules Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Netupitant and Palonosetron Hydrochloride Capsules Producing Area Distribution and Sales Area
Table 21. Players Netupitant and Palonosetron Hydrochloride Capsules Products Offered
Table 22. Netupitant and Palonosetron Hydrochloride Capsules Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Netupitant and Palonosetron Hydrochloride Capsules Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share Geographic Region (2018-2023)
Table 27. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Netupitant and Palonosetron Hydrochloride Capsules Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Country/Region (2018-2023)
Table 31. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Netupitant and Palonosetron Hydrochloride Capsules Sales by Country (2018-2023) & (K Units)
Table 34. Americas Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Country (2018-2023)
Table 35. Americas Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Country (2018-2023)
Table 37. Americas Netupitant and Palonosetron Hydrochloride Capsules Sales by Type (2018-2023) & (K Units)
Table 38. Americas Netupitant and Palonosetron Hydrochloride Capsules Sales by Application (2018-2023) & (K Units)
Table 39. APAC Netupitant and Palonosetron Hydrochloride Capsules Sales by Region (2018-2023) & (K Units)
Table 40. APAC Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Region (2018-2023)
Table 41. APAC Netupitant and Palonosetron Hydrochloride Capsules Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Region (2018-2023)
Table 43. APAC Netupitant and Palonosetron Hydrochloride Capsules Sales by Type (2018-2023) & (K Units)
Table 44. APAC Netupitant and Palonosetron Hydrochloride Capsules Sales by Application (2018-2023) & (K Units)
Table 45. Europe Netupitant and Palonosetron Hydrochloride Capsules Sales by Country (2018-2023) & (K Units)
Table 46. Europe Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Country (2018-2023)
Table 47. Europe Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Country (2018-2023)
Table 49. Europe Netupitant and Palonosetron Hydrochloride Capsules Sales by Type (2018-2023) & (K Units)
Table 50. Europe Netupitant and Palonosetron Hydrochloride Capsules Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Netupitant and Palonosetron Hydrochloride Capsules
Table 58. Key Market Challenges & Risks of Netupitant and Palonosetron Hydrochloride Capsules
Table 59. Key Industry Trends of Netupitant and Palonosetron Hydrochloride Capsules
Table 60. Netupitant and Palonosetron Hydrochloride Capsules Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Netupitant and Palonosetron Hydrochloride Capsules Distributors List
Table 63. Netupitant and Palonosetron Hydrochloride Capsules Customer List
Table 64. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Netupitant and Palonosetron Hydrochloride Capsules Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Netupitant and Palonosetron Hydrochloride Capsules Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Netupitant and Palonosetron Hydrochloride Capsules Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Netupitant and Palonosetron Hydrochloride Capsules Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Netupitant and Palonosetron Hydrochloride Capsules Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Netupitant and Palonosetron Hydrochloride Capsules Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Helsinn Birex Pharmaceuticals Ltd Basic Information, Netupitant and Palonosetron Hydrochloride Capsules Manufacturing Base, Sales Area and Its Competitors
Table 79. Helsinn Birex Pharmaceuticals Ltd Netupitant and Palonosetron Hydrochloride Capsules Product Portfolios and Specifications
Table 80. Helsinn Birex Pharmaceuticals Ltd Netupitant and Palonosetron Hydrochloride Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Helsinn Birex Pharmaceuticals Ltd Main Business
Table 82. Helsinn Birex Pharmaceuticals Ltd Latest Developments
Table 83. Eurimpharm Arzneimittel GmbH Basic Information, Netupitant and Palonosetron Hydrochloride Capsules Manufacturing Base, Sales Area and Its Competitors
Table 84. Eurimpharm Arzneimittel GmbH Netupitant and Palonosetron Hydrochloride Capsules Product Portfolios and Specifications
Table 85. Eurimpharm Arzneimittel GmbH Netupitant and Palonosetron Hydrochloride Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Eurimpharm Arzneimittel GmbH Main Business
Table 87. Eurimpharm Arzneimittel GmbH Latest Developments
Table 88. Sichuan Kelun Pharmaceutical Co., Ltd Basic Information, Netupitant and Palonosetron Hydrochloride Capsules Manufacturing Base, Sales Area and Its Competitors
Table 89. Sichuan Kelun Pharmaceutical Co., Ltd Netupitant and Palonosetron Hydrochloride Capsules Product Portfolios and Specifications
Table 90. Sichuan Kelun Pharmaceutical Co., Ltd Netupitant and Palonosetron Hydrochloride Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Sichuan Kelun Pharmaceutical Co., Ltd Main Business
Table 92. Sichuan Kelun Pharmaceutical Co., Ltd Latest Developments
Table 93. CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Basic Information, Netupitant and Palonosetron Hydrochloride Capsules Manufacturing Base, Sales Area and Its Competitors
Table 94. CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Netupitant and Palonosetron Hydrochloride Capsules Product Portfolios and Specifications
Table 95. CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Netupitant and Palonosetron Hydrochloride Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Main Business
Table 97. CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Latest Developments
Table 98. QILU PHARMACEUTICAL CO.,LTD Basic Information, Netupitant and Palonosetron Hydrochloride Capsules Manufacturing Base, Sales Area and Its Competitors
Table 99. QILU PHARMACEUTICAL CO.,LTD Netupitant and Palonosetron Hydrochloride Capsules Product Portfolios and Specifications
Table 100. QILU PHARMACEUTICAL CO.,LTD Netupitant and Palonosetron Hydrochloride Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. QILU PHARMACEUTICAL CO.,LTD Main Business
Table 102. QILU PHARMACEUTICAL CO.,LTD Latest Developments
List of Figures
Figure 1. Picture of Netupitant and Palonosetron Hydrochloride Capsules
Figure 2. Netupitant and Palonosetron Hydrochloride Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Netupitant and Palonosetron Hydrochloride Capsules Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 300 mg/Capsule 1 Capsule/Box
Figure 10. Product Picture of 0.5 mg/Capsule 1 Capsule/Box
Figure 11. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Type in 2022
Figure 12. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Type (2018-2023)
Figure 13. Netupitant and Palonosetron Hydrochloride Capsules Consumed in Moderate Emetogenic Chemotherapy
Figure 14. Global Netupitant and Palonosetron Hydrochloride Capsules Market: Moderate Emetogenic Chemotherapy (2018-2023) & (K Units)
Figure 15. Netupitant and Palonosetron Hydrochloride Capsules Consumed in Highly Emetogenic Chemotherapy
Figure 16. Global Netupitant and Palonosetron Hydrochloride Capsules Market: Highly Emetogenic Chemotherapy (2018-2023) & (K Units)
Figure 17. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Application (2022)
Figure 18. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Application in 2022
Figure 19. Netupitant and Palonosetron Hydrochloride Capsules Sales Market by Company in 2022 (K Units)
Figure 20. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Company in 2022
Figure 21. Netupitant and Palonosetron Hydrochloride Capsules Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Company in 2022
Figure 23. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Netupitant and Palonosetron Hydrochloride Capsules Sales 2018-2023 (K Units)
Figure 26. Americas Netupitant and Palonosetron Hydrochloride Capsules Revenue 2018-2023 ($ Millions)
Figure 27. APAC Netupitant and Palonosetron Hydrochloride Capsules Sales 2018-2023 (K Units)
Figure 28. APAC Netupitant and Palonosetron Hydrochloride Capsules Revenue 2018-2023 ($ Millions)
Figure 29. Europe Netupitant and Palonosetron Hydrochloride Capsules Sales 2018-2023 (K Units)
Figure 30. Europe Netupitant and Palonosetron Hydrochloride Capsules Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules Revenue 2018-2023 ($ Millions)
Figure 33. Americas Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Country in 2022
Figure 34. Americas Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Country in 2022
Figure 35. Americas Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Type (2018-2023)
Figure 36. Americas Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Application (2018-2023)
Figure 37. United States Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Region in 2022
Figure 42. APAC Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Regions in 2022
Figure 43. APAC Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Type (2018-2023)
Figure 44. APAC Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Application (2018-2023)
Figure 45. China Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Country in 2022
Figure 53. Europe Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Country in 2022
Figure 54. Europe Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Type (2018-2023)
Figure 55. Europe Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Application (2018-2023)
Figure 56. Germany Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Application (2018-2023)
Figure 65. Egypt Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Netupitant and Palonosetron Hydrochloride Capsules in 2022
Figure 71. Manufacturing Process Analysis of Netupitant and Palonosetron Hydrochloride Capsules
Figure 72. Industry Chain Structure of Netupitant and Palonosetron Hydrochloride Capsules
Figure 73. Channels of Distribution
Figure 74. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Forecast by Region (2024-2029)
Figure 75. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のホスネツピタント＆塩酸パロノセトロンカプセル市場予測 2023年-2029年] (コード：LP23DC11002)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のホスネツピタント＆塩酸パロノセトロンカプセル市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のタムスロシン塩酸塩徐放性カプセル市場予測 2023年-2029年
  • 世界の塩酸オキシコドン徐放性薬剤市場予測 2023年-2029年
  • 世界のニロチニブカプセル市場予測 2023年-2029年
  • 世界の医薬品用トラゾドン塩酸塩市場予測 2023年-2029年
  • 世界のメトキシフェナミン塩酸塩原薬市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆